Quinn, G. R., Hellkamp, A. S., Becker, R. C., Berkowitz, S. D., Breithardt, G., Fox, K. A., … Singer, D. E. (2016). Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. In CIRCULATION (Vol. 134).

Quinn, Gene R., Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A. Fox, Werner Hacke, et al. “Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.” In CIRCULATION, Vol. 134, 2016.

Quinn GR, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KA, et al. Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. In: CIRCULATION. 2016.

Quinn, Gene R., et al. “Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.” CIRCULATION, vol. 134, 2016.

Quinn GR, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KA, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Patel MR, Piccini JP, Singer DE. Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. CIRCULATION. 2016.